Gritstone Oncology CEO on developing second generation Covid-19 vaccine

Gritstone Oncology CEO Andrew Allen joined Jim Cramer on "Mad Money" to explain the company's agreement with the National Institute for Allergy and Infectious Diseases to start testing a new vaccine for emerging coronavirus variants.